Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.430
+0.150 (6.58%)
At close: Mar 4, 2026, 4:00 PM EST
2.425
-0.005 (-0.21%)
After-hours: Mar 4, 2026, 4:12 PM EST

Century Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-26.48-126.57-136.67-130.93-95.82-53.58
Depreciation & Amortization
12.8713.313.048.443.751.4
Stock-Based Compensation
8.212.6914.6210.674.660.88
Other Adjustments
3.03-0.2811.281.931.215.17
Changes in Accounts Payable
-0.12-1.47-2.36-4.79-1.852.06
Changes in Accrued Expenses
-2.491.6-0.733.961.492.33
Changes in Unearned Revenue
-113.34-6.59-2.24117.99--
Changes in Other Operating Activities
0.08-2.8214.716.79-2.440.47
Operating Cash Flow
-112.02-110.14-88.3514.05-89-41.27
Capital Expenditures
-1.16-0.15-13.74-30.6-44.97-9.83
Purchases of Investments
-52.98-119.55-209.03-254-330.03-49.86
Proceeds from Sale of Investments
169.89176.79283.9271.4876.6741.65
Payments for Business Acquisitions
--9.61----4.72
Investing Cash Flow
115.7547.4861.13-13.13-298.34-22.76
Long-Term Debt Issued
-----9.73
Long-Term Debt Repaid
---10.24---
Net Long-Term Debt Issued (Repaid)
---10.24--9.73
Issuance of Common Stock
-0.4874.560.5227.16255.8238.1
Net Common Stock Issued (Repurchased)
-0.4874.560.5227.16255.8238.1
Issuance of Preferred Stock
----159.63-
Net Preferred Stock Issued (Repurchased)
----159.63-
Other Financing Activities
----2.33-0.14
Financing Cash Flow
-0.4874.56-9.7327.16417.7747.69
Net Cash Flow
3.2411.91-36.9428.0830.43-16.34
Free Cash Flow
-113.18-110.29-102.08-16.55-133.97-51.09
FCF Margin
-99.87%-1673.84%-4567.52%-318.37%--
Free Cash Flow Per Share
-1.32-1.40-1.72-0.29-4.14-6.83
Levered Free Cash Flow
-130.63-122.69-138.23-29.15-139.84-47.4
Unlevered Free Cash Flow
-140.49-136.25-139.9-32.14-138.94-57.46
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q